🇺🇸 FDA
Patent

US 7851228

Methods for screening agents that modulate presenilin activity and A-β production

granted A61PA61P25/28A61P43/00

Quick answer

US patent 7851228 (Methods for screening agents that modulate presenilin activity and A-β production) held by The Regents of the University of California expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61P, A61P25/28, A61P43/00